skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Pharmacoeconomics & Outcomes News remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cerebral oedema large burden in US patients with large hemispheric infarction
Cerebral oedema large burden in US patients with large hemispheric infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cerebral oedema large burden in US patients with large hemispheric infarction

PharmacoEconomics & outcomes news, 2021-09 (886), p.6-6

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
2
Metastatic renal-cell carcinoma treated with first-line monotherapy: considerable burden, high unmet needs
Metastatic renal-cell carcinoma treated with first-line monotherapy: considerable burden, high unmet needs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metastatic renal-cell carcinoma treated with first-line monotherapy: considerable burden, high unmet needs

PharmacoEconomics & outcomes news, 2021-05 (877), p.13-13

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
3
CKD: understanding the high burden of disease, healthcare costs and mortality in the US
CKD: understanding the high burden of disease, healthcare costs and mortality in the US
Material Type:
Artigo 		Adicionar ao Meu Espaço

CKD: understanding the high burden of disease, healthcare costs and mortality in the US

PharmacoEconomics & outcomes news, 2021-02 (871), p.8-8

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
4
Benefits of proposed faster drug approval in the UK questionable
Benefits of proposed faster drug approval in the UK questionable
Material Type:
Artigo 		Adicionar ao Meu Espaço

Benefits of proposed faster drug approval in the UK questionable

PharmacoEconomics & outcomes news, 2017-12 (792), p.31-31

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
5
Eluvia drug-eluting stents for symptomatic PAD may be cost saving in Australia
Eluvia drug-eluting stents for symptomatic PAD may be cost saving in Australia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Eluvia drug-eluting stents for symptomatic PAD may be cost saving in Australia

PharmacoEconomics & outcomes news, 2021-07 (882), p.11-11

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
6
Prothrombin complex concentrate for off-label use: 3- vs 4-factor
Prothrombin complex concentrate for off-label use: 3- vs 4-factor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prothrombin complex concentrate for off-label use: 3- vs 4-factor

PharmacoEconomics & outcomes news, 2018-07 (807), p.29-29

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
7
Adjuvanted vs high-dose trivalent influenza vaccines: comparable clinical and economic benefits among elderly in the US
Adjuvanted vs high-dose trivalent influenza vaccines: comparable clinical and economic benefits among elderly in the US
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvanted vs high-dose trivalent influenza vaccines: comparable clinical and economic benefits among elderly in the US

PharmacoEconomics & outcomes news, 2021-04 (876), p.3-3

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
8
Insulin degludec good value for money in T2DM with high CV risk
Insulin degludec good value for money in T2DM with high CV risk
Material Type:
Artigo 		Adicionar ao Meu Espaço

Insulin degludec good value for money in T2DM with high CV risk

PharmacoEconomics & outcomes news, 2019-07 (832), p.17-17

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
9
Adopting ACC/AHA guidelines on hypertension costly in China
Adopting ACC/AHA guidelines on hypertension costly in China
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adopting ACC/AHA guidelines on hypertension costly in China

PharmacoEconomics & outcomes news, 2019-07 (832), p.4-4

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
10
Dexmedetomidine and propofol sedation have similar ICU costs
Dexmedetomidine and propofol sedation have similar ICU costs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dexmedetomidine and propofol sedation have similar ICU costs

PharmacoEconomics & outcomes news, 2020-09 (862), p.10-10

Auckland: Springer Nature B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1)

Data de Publicação 

De até
Refinar
  1. Antes de2010  (1.560)
  2. 2010Até2012  (2.526)
  3. 2013Até2015  (2.628)
  4. 2016Até2019  (3.711)
  5. Após 2019  (1.785)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.